1. Trang chủ
  2. » Kỹ Thuật - Công Nghệ

Pharmaceutical Substances Syntheses, Patents, Applications - Part 65 docx

10 612 0

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 10
Dung lượng 277,06 KB

Nội dung

Diflucortolone valerate 641 CH3 1. CH,COOK, C,H,OH 2. H2F2. CHCl, I * 11 N,N'-dibromo-5.5- dimethylhydontoin pyridine + (I LcH3 + F] voleryl Diflucortalone valerote chloride Reference(s): DE 1 21 1 194 (Schering; 27.7.1963) continuation of DE 1 169 444. DE 1 169 444 (Schering; 22.2.196 1). Kieslich, K. et al.: Arzneim Forsch. (ARZNAD) 26, 1462 (1976). (alternative syntheses described) Fonnularion(s): cream 0.1 %; ointment 0.1 % Dude Nnme(s): D: Neribas (Schering) Nerisona (Schering) Nerisona C (Schering)- comb. Travocort (Schering)-comb. F: Nerisone (Schering; as valerate) Nerisone C (Schering; as valerate)-comb. GB: Nerisone (Schering) I: Cortical (Cabcr) Cortifluoral (Schering)- comb. Dermaflogil (Nuovo Cons. Sanit. Naz.)-comb. Derrneval (Firma) J: Derrnobios (Biotekfarma)- comb. Dcrvin (Boniscontro & Gazzone) Dicortal (Medici) Flu-Cortanest (Piam) Impetex (Roche)-comb. Nerisona (Schering) Nerisona C (Schedng)- comb. Temetex (Roche) several combination preparations Afusona (Toyama) Arusona (Hotta) Dertron (Sankyo) Lizatlone (Kaken) Lorizon (Shinshin) Neridalon (Taiyo) Nerisona (Nippon Schcring) Sawatolone (Sawai) Texrneten (Roche) Youtolon (Tatsumi) 642 D Diflunisal Diflunisal ATC: N02BA11 Use: anti-inflammatory, analgesic, antipyretic RN: 22494-42-4 MF: C,,H,F,O, MW: 250.20 EINECS: 245-034-9 LD,,: 439 mgtkg (M, p.0.); 392 mglkg (R, p.0.) CN: 2',4'-difluoro-4-hydroxy[l ,I '-biphenyl]-3-carboxylic acid 2.4-difluoro- onisole aniline Reference(s): Hannah, J. et at.: J. Med. Chem. (JMCMAR) 21,1093 (1978) DE 1 61 8 663 (Merck & Co.; appl. 3.3.1967; USA-prior. 8.9.1966). DAS 2 532 559 (Merck & Co.; appl. 21.7.1975; USA-prior. 22.7.1974, 16.4.1975, 1.5.1975). US 3 674 870 (Merck & Co.; 4.7.1972; appl. 9.6.1970; USA-prior. 23.12.1964, 8.9.1966, 19.1.1968). US 3 68 1 445 (Merck & Co.; 1.8.1972; appl. 19.1.1968; USA-prior. 23.12.1964, 8.9.1966). US 3 714 226 (Merck & Co.; 30.1.1973; appl. 9.6.1970; prior. 23.12.1964, 8.9.1966, 19.1.1968). 4-(2,4-difluoro- alternative syntheses: US 3 992 459 (Merck & Co.; 16.1 1.1976; appl. 1.5.1975). US 4 131 618 (Merck & Co.; 26.12.1978; appl. 29.12.1977). US 4 225 730 (Merck & Co,; 30.9.1980; appl. 11.5.1978; prior. 22.7.1974, 16.4.1975) Diflunisal Formulation(s): tabl. 250 mg, 500 mg phenyl)phenol (1) Trade Name(s): D: Fluniget (Ferlux; 1982); Artrodol (AGIPS) Reuflos (Roussel) wfrn Difludol (Edmond) J: Dolobid (Merck-Banyu; F: Dolobis (Merck Sharp & Diflusan (Leben's) 1984) Dohme-Chibret: 198 1) Dolisal (Guidotti) USA: Dolobid (Merck; 1982) GB: Dolobid (Morson; 1978) Dolobid (Merck Sharp & I: Adomal (Malesci) Dohme; 1979) Aflogos (Biomedica Fluodonil (Biologici Italia) Foscama; as arginine salt) Hustar (Firma) Difuprednate D 643 ATC: D07AC19 Use: topical glucocorticoid RN: 23674-86-4 MF: C2,H3,F207 MW: 508.56 EINECS: 245-815-4 LD,: >4 glkg (M, p.0.); >4 glkg (R, PO.) CN: (6a,11~)-21-(acetyloxy)-6,9-difluoro-11-hydroxy- 17-(1-oxobutoxy)pregna- I ,4-diene-3,20-dione 6a.9-difluoro- trimethyl prednisolone orthobutyrate 1 1. oxalic acld Difluprednote I US 3 780 177 (Warner-Lambcrt; 18.12.1973; I-prior. 6.6.1967). ZA 6 803 686 (Warner-Lambert; appl. 21.5.1968; I-prior. 16.6.1967). Gardi, R. et al.: J. Med. Chem. (JMCMAR) 15, 556 (1972). Fonnulation(s): gel 0.05 % Tmde Name(s): F: Epilopic (Gerda) J: Myser (Mitsubishi Chem Tokyo Tanabe) Digitoxin ATC: COlAA04 Use: cardiac glycoside, cardiotonic RN: 71-63-6 MF: C4,HMOI3 MW: 764.95 EINECS: 200-760-5 LD,,: 0.18 mglkg (cat, p.0.) CN: (3~,5~)-3-[(0-2,6-dideoxy-~-ribo-hexopyranosy-(l+4)-0-2,6-dideoxy-~-~-ribo-hexopyranosyl- (l-t4)-2,6-dideoxy-~-~-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide 644 D Digitoxin extraction Digitalis purpurea + OH AH purpureoglycoside A (I) enzymatic hydrolysis [Digilonidose] 1- Digitoxin from Digitalis lanato Reference(s): a DRP 646 930 (Sandoz; appl. 1933). US 2 449 673 (Wyeth; 1948; prior. 1944). US 2 557 916 (Wyeth; 1951; appl. 1948). US 2 615 884 (Wyeth; 1952; prior. 1948). HU 155 252 (Richter Gedeon; appl. 14.12.1966). b HU 156 753 (Richter Gedeon; appl. 7.1.1968). IN 62 497 (Council of Scientifique & Industrial Research; appl. 17.9.1958). alternative synrheses: Ullmanns Encykl. Tech. Chem., 3. Aufl., Vol. 8,229 DOS 2 006 9i6 (Deutsche Akademie der Wissenschaften; appl. 16.2.1970; DDR-prior. 15.8.1969). Formulation(s): amp. 0.1 mglml, 0.25 mglml; eye drops 0.02 mg/ml; lotion; tabl. 0.05 mg, 0.07 mg, 0.1 mg, 0.25 mg Digoxin D 645 Name(s): : Digicor (Henning) Digimed (Hormosan) Digimed (TrommsdorK) Digimerck (Merck) Digipural (Schaper & Briimmer) Digitoxin Didier (Hormosan) Digitoxin Hameln (Harneln) Digophton-Augentropfen (ankerpharm) Dirautheon (Robugen)- comb. Ditaven (Cascan)-comb. Ditaven Lot. (Cascan) GB: mono-glycocard (R.A.N.) Recorsan-Herzdragees I: (Recorsan) Tardigal (Beiersdorf) Targital (Beiersdori] generics J: F: Digitaline Nativelle (Procter & Gamble) USA: Ditavkne (Pharmad6veloppement)- comb. Nativelle Digitaline (Wilcox); wfm Digifar (Farmila)-comb. Digitalina (Procter & Gamble) Digitos (Formulario Naz.) Digitoxin (Shionogi) Digitoxin-Sandoz (Sankyo) Crystodigin (Lilly) Digoxin ATC: COlAAO5 Use: cardiac glycoside, cardiotonic RN: 20830-75-5 MF: C,,HMOI4 MW: 780.95 EINECS: 244-068-1 LD,: 7.670 mglkg (M, i.v.); 17.78 mglkg (M, p.0.); 25 mgkg (R, i.v.); 28.27 mglkg (R, p.0.) CN: (3~,5~,12~)-3-[(0-2,6-dideoxy-~-~-ribo-hexopyranosy1-(1~4)-0-2,6-dideox~-~-~-ribo-hexo~~ranos~l- (14)-2,6-dideoxy-~-~-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide @ from Digitalis lonata by extraction H KOH. DMF '3'3 a-acetyldigoxin Digaxin 646 D Dihydralazine Keference (s): a GB 337 091 (Wcllcome Found.; appl. 1929). Smith, S.: J. Chem. Soc. (JCSOA9) 1930, 508. IN 62 497 (Council of Scientific & Industrial Research; appl. 17.9.1958). HU 149 778 (Richter Gedeon; appl. 8.1 2.1959). HU 151 897 (Richter Gedeon; appl. 29.2.1964). HU 156 753 (Richter Gedeon; appl. 7.6.1968). DAS 2 225 039 (VEB Arzneimittelwerke Dresden; appl. 23.5.1972; DDR-prior. 24.1.1972) Ullmanns Encykl. Tech. Chem., 3. Aufl., Vol. 8, 231. b DD 70 088 (C. Lindig, K. Repke; appl. 1.1 1.1963). alternative synthesis: DD 134 644 (VEB Arzneimittelwerke Dresden; appl. 6.10.1977). Formulatiorz(s): amp. 0.1 mglml, 0.25 mglml, 0.2 mg/ml, 0.5 mg12 ml; cps. 0.1 mg, 0.2 mg; drops; tabl. 0.125 mg, 0.25 mg Trade Namefs): D: Digacin (Beiersdorf-Lilly) GB: Lanoxin (Glaxo Wellcome) J: Digosin (Chugai) Dilanacin (ASTA Medica I: Digomal (Malesci) Digosin Erixir (Chugai) AW D) Digos (Biologici Italia) Digoxin (Yamanouchi) Lanicor (Boehringer Digoss (Formulario Naz.; Lanoxin (Wellcome- Mannh.) Sifra) Tanabe) Lenoxln (Glaxo Wellcome) . D~gossina (Scfrn) USA: Lanoxicaps (Glaxo Novod~gal Amp. Eudigox (Astra-Simes) Wellcome) (Beiersdorf) Lanicor (Roehringer Lanox~n (Glaxo Wellcome) F: Dlgox~ne Nativelle (Procter Mannh ) generic & Gamble) Lanoxin (Wellcome) Dihydralazine (Dihydrallazine) ATC: C02DBOI Use: antihypertensive RN: 484-23-1 MF: C,H,,,N, MW: 190.21 ElNECS: 207-605-0 LD5,,: 300 mgkg (M, i.v.) CN: 2,3-dihydro-l ,4-phthalazinedione dihydrazone sulfate (1:l) RN: 7327-87-9 MF: C8HI,,N,. H,SO, MW: 288.29 EINECS: 230-808-0 LD,,,: 400 mglkg (M, p.0.); 400 mglkg (R, p.0.) Dihydrocodeine D 647 CN t CS, CN hydrazine hydrate phtholo- carbon nltrils disulfide (teference(s): DE 845 200 (Cassella; appl. 1951). DE 847 748 (Ciba; appl. 1949; CH-prior. 1947). Fomulation(s): tabl. 25 mg, 50 mg (as sulfatc) Tmde Name(s): D: Adelphan-Esidrix (Novartis Obsilazin (Isis Pharma)- Pharma)-comb? comb. Depressan (OPW) Triniton (Apogepha) ~ii~zin (Henning Berlin) 'lk-Torrat (Boehringer Nepresol (Novartis Mannh.)-comb. Pharma)-comb. F; NCpressol (Novartls; as hydrogen sulfate) Dihydralazine Trasipressol (Novartis; as hydrogen sulfate)-comb. I: Adelfan (Novartis)-comb. Ipogen (Gcnti1i)-comb. Nepresol (Novartis) Dihydrocodeine (Drocode) ATC: N02AA08 Use: antitussive, analgesic RN: 125-28-0 MF: C,,H,,NO, MW: 301.39 EINECS: 204-732-3 LD,,: 80 mgkg (M, i.v.) CN: (5a,6a)-4,5-epoxy-3-methoxy-17-mcthylmorphinan-6-ol hydrogen tartrate (1:l) RN: 5965-13-9 MF: C,RH,3N03 . C4H606 MW: 451.47 EINECS: 227-747-7 LD,o: 359 mg/kg (R, p.0.) codeine Dihydracodeine L Reference(s): Ehrhart, Ruschig I, 11 8. Stein, A.: Pharmazie (PHARAT) 10, 180 (1955). Formulation(s): cps. 20 mg; sol. 10 mg/g; s. r. tabl. 60 mg, 90 mg, 120 mg; syrup 12.1 mgl5 ml; tabl. 10 mg (as hydrogen tartrate) Tmde Name(s): D: Antibex forte (Lappe)- Antitussivum (Ysatfabrik)- Makatussin (Roland)- - - comb. comb. comb. DHC (Mundipharma) Paracodin (Knoll) 648 D Dihydroergocristine Remedacen (RhBne- Remedeme (Napp)-comb. USA: DHC plus (Purdue Poulcnc Rorer) 1: Alla Paracodina (Knoll)- Frcderick; as bitartrate) Tiamon (Tcmm1er)-comb. comb. Synalgos-DC (Wyeth- F: Dicodin (ASTA Mcdica; as Paracodina (Knoll) Ayersl; as bitartrate) tartrate) Sciroppo Knoll paracodina GB: DF- 1 18 forte (Napp) (Knoll)-comb. DHC Contiums (Napp) Tavolette (Knoll) Dihydroergocristine ATC: C04AE04 Usc: adrenolytic, sympatholytic RN: 17479-19-5 MF: C3SH4,N,0S MW: 61 1.74 EINECS: 241-493-4 CN: (5'a,lOa)-9,I0-dihydro-l2'-hydroxy-2'-(l-methylethyl)-5'-(phenylmethyl)crgotaman-3',6',l8-tnone monomesylate RN: 24730-10-7 MF: C3sf14,NSOs - CH403S MW: 707.85 EINECS: 246-434-6 LD5,,: 70 mgkg (M, i.v.); >2500 mglkg (M, p.0.); 91 mglkg (R, i.v.); 2643 mglkg (R, p.0.); >50 mglkg (dog, i.v.); >I250 mglkg (dog, p.0.) constituent of dihydroergotoxine (q. v.) ergocrisiine Referencers): Stoll, A.; Hofmann, A,: Helv. Chim. Acta (fICACAV) 26, 2070 (1943). Dihydroergocristine combination with pentoxifylline: BE 865 891 (Roussel-Uclaf; appl. 11.4.1978; F-prior. 12.4.1977). Fnrmulation(s): amp. 0.3 mglml; sol. 1 mglml; tabl. 1.5 mg (as mesylate) Trade Name(s): D: Bellaserp (Atmos)-comb.; Panthesin-Hydergin Decril (Damor) wfm (Sandoz)-comb.; wfm Defluina (Teofarma) Briserin (Sandoz)-comb.; Rexiluven (Sandoz)-comb.; Diertina (Poli) wfm wfm Difluid (Bioprogress) Card-Hydergin (Sandoz)- comb.; wfrn Decme (Spitzner); wfrn Decme (Zy ma); wfm Defluina (Natrapharm)- comb.; wfrn Enirant Tropflosung (Dcsitin); wfm Nehydrin (TAD); wfrn Sinedyston (Steiner); wfm Ergo (Foletto) Vertebran N (Rentschler); Ergotina (1st. Chim. Inter.) wfm Gral (Boniscontro & Wallerox (Sandoz); wfm Gazzone) F: Cervilanc (Cassenne)- Sandoven (Sandoz)-comb. comb. Unergol (Poli) IskCdyl (Pierre Fabre; as mesy1ate)-comb. I: Brinerdina (Sandoz)-comb. Dihydroergotamine D 649 * Dihydroergotamine ATC: N02CAOI Use: sympatholytic, antimigraine agent RN: 511-12-6 MF: C,,H,,N505 MW: 583.69 EINECS: 208-123-3 LDN: 1 18 mgkg (M, i.v.) CN: (5'a,10a)-9,10-dihydro-l2'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione monomesylate RN: 6190-39-2 MF: C33H37N50s. CH403S MW: 679.80 EINECS: 228-235-6 LD,,: >2 gkg (M, p.0.); >2 gkg (R, p.4 tartrate (2:l) RN: 5989-77-5 MF: C3,H3,N5Oy l/2C4H606 MW: 131 7.46 EINECS: 227-8 16-1 LD,: 118 mgkg (M, i.v.); 110 mgkg (R, i.v.) ergotarnine Dihydroergotarnine Stoll, A,; Hoffmann, A.: Helv. Chim. Acta (HCACAV) 26,2070 (1943). DE 883 153 (Sandoz; appl. 1941; CH-prior. 1940). naral formulation: DOS 2 802 113 (Sandoz; appl. 19.1.1978). Formulation(s): amp. 1 mg, 2 mg; s. r. cps. 2.5 mg; 5.0 mg; tabl. 1 mg, 2.5 mg (as mesylate) Trade Name(s): D: Agit (Sanofi Winthrop) Agit (Sanofi Winthrop)- comb. Angionorm (Faimasan) clavigrenin (Hormosan) DET-MS (Rentschler) DHE-Puren (Isis Puren) Dihydergot-fortelretard (Novartis Pharma) Dihydergot-plus (Novartis Pharma)-comb. Dihytamin (ASTA Medica AWD) Effortil (Boehringer 1ng.)- comb. Embolex (Novartis Pharma)-comb. Ergo-Lonarid (Boehringer 1ng.)-comb. Ergomimet (Klinge) Ergont (Desitin) ergotam (ct-Arzneimittel) Optalidon (Novartis Pharma) Tonopres-forte (Boehringer Ing.) Venelbin (Hoechst)-comb. Verladyn (Verla) F: Ikaran (Pierre Fabre; as mesylate) SCglor (Sanofi Winthrop; as mesylate) Tamik (EG Labo; as mesylate) GB: Dihydergot (Sandoz); wfm I: Diidergot (Sandoz) Ikaran (Formenti) Seglor (Synthelabo) J: Dihydergot (Sandoz- Sankyo) USA: DHE 45 (Novartis) 650 D Dihydroergotoxine Dihydroergotoxine ATC: CO~AE (Dihydroergocornine Dihydro-a-ergocryptine) Use: sympatholytic, cognition adjuvant RN: 11032-41-0 MF: unspecified MW: unspecified LD,,: 71 mgkg (M, s.c.) CN: dihydroergotoxine mesy late RN: 8067-24- 1 MF: unspecified MW: unspecified "ergotoxine" (ergocornine + ergacristine + ergocryptine A 1:l:l) "Dihydroergotoxine' Reference(s): Stoll, A.; Hofmann, A,: Helv. Chim. Acta (HCACAV) 26, 2070 (1943). DE 883 153 (Sandoz; appl. 1941; CH-prior. 1940). nasal formulation: DOS 2 802 113 (Sandoz; appl. 19.1.1978). Formulation(s): amp. 0.3 mglml, 1.5 mgI5 ml; sol. 1 mglml, 2 mglml; tabl. 2 mg Trade Nume(s): D: Circanol (3M Medica) Dacoren (Nattermann) DCCK (Rentschler) Defluina (Nattermann) Enirant (gepepharm) Ergodesit (Desitin) ergoplus (Hormosan) ergotux (ct-Arzneimittel) Hydergid-forte (Novartis Pharma) Hydro-Cebral-ratiopharm (ratiopharm) Nehydrin (TAD) Orphol (Opfermann) Sponsin (Farmasan) F: Capergyl (ThCrica) Ergodose (Murat; as mesylate) Hydergine (Novartis; as mesylate) Optamine (ThCraplix) PCrtnan (Sanofi Winthrop) GB: Hydergine (Novartis) I: Coristin (San Carlo) Hydergina (Sandoz) Ischelium (Polifarma) Ischelium Papaverina (Po1ifarma)-comb. with papaverine hydrochloride Progeril (Midy) Progeril Papaverina (Midy)-comb, with papaverine Trelidat (Coop. Farm.) Visergil (Sandoz)-comb. J: Hydergine (Sandoz- Sankyo) USA: Circanol (Riker); wfm Deapril (Mead Johnson); wfm Hydergine (Sandoz); wfrn Hydro-Ergoloid (Schein); wfm Hydro-Ergot (Interstate); wfrn . 7 1-6 3-6 MF: C4,HMOI3 MW: 764.95 EINECS: 20 0-7 6 0-5 LD,,: 0.18 mglkg (cat, p.0.) CN: (3~,5~ )-3 -[ ( 0-2 ,6-dideoxy-~-ribo-hexopyranosy-(l+4 )-0 -2 ,6-dideoxy- ~-~ -ribo-hexopyranosyl- (l-t4 )-2 ,6-dideoxy- ~-~ -ribo-hexopyranosyl)oxy ]-1 4-hydroxycard-20(22)-enolide. (3~,5~,12~ )-3 -[ ( 0-2 ,6-dideoxy- ~-~ -ribo-hexopyranosy 1-( 1~4 )-0 -2 ,6-dideox ~-~ -~ -ribo-hexo~~ranos~l- (14 )-2 ,6-dideoxy- ~-~ -ribo-hexopyranosyl)oxy ]-1 2,14-dihydroxycard-20(22)-enolide @ from Digitalis lonata. 24 1-4 9 3-4 CN: (5'a,lOa )-9 ,I0-dihydro-l2'-hydroxy-2&apos ;-( l-methylethyl )-5 &apos ;-( phenylmethyl)crgotaman-3',6',l8-tnone monomesylate RN: 2473 0-1 0-7 MF: C3sf14,NSOs - CH403S

Ngày đăng: 02/07/2014, 02:20

TỪ KHÓA LIÊN QUAN